Literature DB >> 35070423

High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.

Zhengxiao Wei1, Xiaoqiong Duan2, Qi Li3, Qingfeng Li1, Yu Wang3.   

Abstract

BACKGROUND: Ran-specific binding protein 1 (RANBP1) is involved in the regulation of the cell cycle, while its role in hepatocellular carcinoma (HCC) is unknown. Therefore, we aimed to demonstrate the association of RANBP1 with clinicopathologic features and potential biological functions in HCC based on The Cancer Genome Atlas (TCGA) data.
METHODS: We assessed RANBP1 expression and its correlation with clinicopathologic features and evaluated the prognostic value of RANBP1 with Kaplan-Meier survival analysis and the MethSurv database. Univariate and multivariate Cox regression analyses were conducted to elucidate the factors responsible for prognosis. The identification of a co-expression network and the analysis of related biological events with RANBP1 in HCC were assessed using LinkedOmics. Moreover, gene set enrichment analysis (GSEA) was employed to annotate the biological function of RANBP1. We also explored the correlation between RANBP1 and tumor immune infiltrates using a single sample GSEA (ssGSEA).
RESULTS: The expression of RANBP1 was found significantly elevated in HCC and linked to advanced T stage and histopathological grade. Up-regulated RANBP1 expression was linked to poor prognosis. High DNA methylation levels of RANBP1 were significantly linked to very poor overall survival (OS). Co-expression network analysis revealed that RANBP1 was involved in ribosome, spliceosome, deoxyribonucleic acid (DNA) replication, ribonucleic acid (RNA) transport, and cell cycle. GSEA showed enrichment of G2M-checkpoint, Wingless and Int-1 (Wnt) cell signaling, and DNA repair in the RANBP1 high-expression phenotype. By using ssGSEA analysis, the increased RANBP1 expression was positively linked to the immune infiltration level of T helper cell type-1 (Th1) and negatively linked to the immune infiltration levels of T helper cell type-17 (Th17).
CONCLUSIONS: Findings suggest that RANBP1 may play a pivotal role in HCC prognosis and can potentially serve as a candidate biosignature and as a therapeutic target for HCC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); Ran-specific binding protein 1 (RANBP1); The Cancer Genome Atlas database (TCGA database); immune infiltration; prognosis

Year:  2021        PMID: 35070423      PMCID: PMC8748041          DOI: 10.21037/jgo-21-541

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  51 in total

1.  Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients.

Authors:  Hideyuki Ubukata; Gyou Motohashi; Takanobu Tabuchi; Hiroyuki Nagata; Satoru Konishi; Takafumi Tabuchi
Journal:  J Surg Oncol       Date:  2010-12-01       Impact factor: 3.454

2.  RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner.

Authors:  W M Rensen; E Roscioli; A Tedeschi; R Mangiacasale; M Ciciarello; S A Di Gioia; P Lavia
Journal:  Oncogene       Date:  2009-03-09       Impact factor: 9.867

3.  Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.

Authors:  Daniela Sia; Yang Jiao; Iris Martinez-Quetglas; Olga Kuchuk; Carlos Villacorta-Martin; Manuel Castro de Moura; Juan Putra; Genis Camprecios; Laia Bassaganyas; Nicholas Akers; Bojan Losic; Samuel Waxman; Swan N Thung; Vincenzo Mazzaferro; Manel Esteller; Scott L Friedman; Myron Schwartz; Augusto Villanueva; Josep M Llovet
Journal:  Gastroenterology       Date:  2017-06-15       Impact factor: 22.682

4.  Characterization of Ran-driven cargo transport and the RanGTPase system by kinetic measurements and computer simulation.

Authors:  Dirk Görlich; Michael J Seewald; Katharina Ribbeck
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

5.  Toil enables reproducible, open source, big biomedical data analyses.

Authors:  John Vivian; Arjun Arkal Rao; Frank Austin Nothaft; Christopher Ketchum; Joel Armstrong; Adam Novak; Jacob Pfeil; Jake Narkizian; Alden D Deran; Audrey Musselman-Brown; Hannes Schmidt; Peter Amstutz; Brian Craft; Mary Goldman; Kate Rosenbloom; Melissa Cline; Brian O'Connor; Megan Hanna; Chet Birger; W James Kent; David A Patterson; Anthony D Joseph; Jingchun Zhu; Sasha Zaranek; Gad Getz; David Haussler; Benedict Paten
Journal:  Nat Biotechnol       Date:  2017-04-11       Impact factor: 54.908

6.  Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.

Authors:  Ilona Kryczek; Mousumi Banerjee; Pui Cheng; Linhua Vatan; Wojciech Szeliga; Shuang Wei; Emina Huang; Emily Finlayson; Diane Simeone; Theodore H Welling; Alfred Chang; George Coukos; Rebecca Liu; Weiping Zou
Journal:  Blood       Date:  2009-05-21       Impact factor: 22.113

7.  Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients.

Authors:  Elena Tassi; Francesca Gavazzi; Luca Albarello; Vladimir Senyukov; Renato Longhi; Paolo Dellabona; Claudio Doglioni; Marco Braga; Valerio Di Carlo; Maria Pia Protti
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.

Authors:  Damian Szklarczyk; John H Morris; Helen Cook; Michael Kuhn; Stefan Wyder; Milan Simonovic; Alberto Santos; Nadezhda T Doncheva; Alexander Roth; Peer Bork; Lars J Jensen; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2016-10-18       Impact factor: 16.971

9.  MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53.

Authors:  Yingchao Wang; Gaoxiong Wang; Xionghong Tan; Kun Ke; Bixing Zhao; Niangmei Cheng; Yuan Dang; Naishun Liao; Fei Wang; Xiaoyuan Zheng; Qin Li; Xiaolong Liu; Jingfeng Liu
Journal:  Oncogenesis       Date:  2019-11-15       Impact factor: 7.485

10.  GSVA: gene set variation analysis for microarray and RNA-seq data.

Authors:  Sonja Hänzelmann; Robert Castelo; Justin Guinney
Journal:  BMC Bioinformatics       Date:  2013-01-16       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.